Inhibitex Inc. (INHX): Today's Featured Drugs Winner
(
) pushed the Drugs industry higher today making it today's featured drugs winner. The industry as a whole closed the day down 2.6%. By the end of trading, Inhibitex Inc rose 99 cents (9.2%) to $11.77 on heavy volume. Throughout the day, 4.3 million shares of Inhibitex Inc exchanged hands as compared to its average daily volume of 1.7 million shares. The stock ranged in a price between $10.68-$12.08 after having opened the day at $10.80 as compared to the previous trading day's close of $10.78. Other companies within the Drugs industry that increased today were:
(
), up 11%,
(
), up 9.6%,
(
), up 9.2%, and
(
), up 7%.
Inhibitex, Inc., a biopharmaceutical company, focuses on the development of differentiated anti-infective products to prevent or treat serious infections. It primarily focuses to treat shingles caused by the varicella zoster virus and chronic infections caused by hepatitis C virus (HCV). Inhibitex Inc has a market cap of $830.7 million and is part of the
sector. Shares are up 314.6% year to date as of the close of trading on Tuesday.
TheStreet Ratings rates Inhibitex as a
. The area that we feel has been the company's primary weakness has been its deteriorating net income.
- You can view the full Inhibitex Ratings Report.
On the negative front,
(
), down 43.3%,
Rosetta Genomics
(
ROSGD
), down 43.3%,
Accelr8 Technology Corporation
(
), down 16.4%, and
Bacterin International Holdings Inc
(
), down 14.7%, were all losers within the drugs industry with
(
) being today's drugs industry loser.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider
(
) while those bearish on the drugs industry could consider
ProShares UltraShort Nasdaq Biotech
(
).
- Find other investment ideas from our top rated ETFs lists.
null
